Literature DB >> 28709940

Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.

Liang Li1, Sharon Shui Yee Leung2, Thomas Gengenbach3, Jiaqi Yu2, Ge Fiona Gao4, Patricia Tang2, Qi Tony Zhou5, Hak-Kim Chan6.   

Abstract

The aim of this study was to investigate the ability of L-leucine (LL) in preventing moisture-induced deterioration in the in vitro aerosolization performance of spray-dried (SD) salbutamol sulfate (SS). Increasing mass fraction of LL (5-80%) were co-spray dried with SS, and the physicochemical properties of the powders were characterized by laser diffraction, X-ray powder diffraction (XRD) and dynamic vapour sorption (DVS). Furthermore, the surface morphology and chemistry of fine particles was analyzed by scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS). The in vitro aerosolization performance of powders stored at different relative humidity (RH) was evaluated by a next generation impactor (NGI). The SD SS powders were moderately hygroscopic and amorphous, of which the uptake of moisture upon storage caused a drop in the aerosolization performance. The results showed that 40% (w/w) LL was sufficient to eliminate the effect of moisture on the aerosolization performance at 60% RH. The formulation containing 40% (w/w) LL also maximized the aerosolization performance of SD SS powders (stored in desiccator) with the emitted fraction being 90.0±1.8%, and the fine particle fraction based on the recovered dose (FPFrecovered) and emitted dose (FPFemitted) being 78.0±3.7% and 86.6±2.9%, respectively. The underlying mechanisms were that the crystalline LL increased the degree of particle surface corrugation, and reduced particle fusion and cohesiveness to facilitate dispersion. However, there is still a great challenge to prevent the moisture-induced deterioration in the aerosolization performance at 75% RH due to the recrystallization of SD SS. In conclusion, LL is a potential excipient for reducing moisture-induced deterioration in the aerosolization performance of SD amorphous powders, but still has drawbacks in preventing the recrystallization-induced deterioration.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dry powder inhalers; L-leucine; Moisture protection; Recrystallization; Salbutamol sulfate; Spray drying

Mesh:

Substances:

Year:  2017        PMID: 28709940     DOI: 10.1016/j.ijpharm.2017.07.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.

Authors:  Nivedita Shetty; Heejun Park; Dmitry Zemlyanov; Sharad Mangal; Sonal Bhujbal; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2018-04-18       Impact factor: 5.875

Review 2.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

3.  Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.

Authors:  Worth Longest; Amr Hassan; Dale Farkas; Michael Hindle
Journal:  Pharm Res       Date:  2022-02-11       Impact factor: 4.200

4.  Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation.

Authors:  Yingjie Chen; Shen Yan; Shengyu Zhang; Quanyi Yin; Xiao Dong Chen; Winston Duo Wu
Journal:  AAPS PharmSciTech       Date:  2022-08-02       Impact factor: 4.026

Review 5.  Inhaled Delivery of Anti-Pseudomonal Phages to Tackle Respiratory Infections Caused by Superbugs.

Authors:  Hak-Kim Chan; Rachel Yoon Kyung Chang
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2021-12-30       Impact factor: 3.440

6.  Effect of storage temperature on the stability of spray dried bacteriophage powders.

Authors:  Sharon S Y Leung; Thaigarajan Parumasivam; An Nguyen; Thomas Gengenbach; Elizabeth A Carter; Nicholas B Carrigy; Hui Wang; Reinhard Vehring; Warren H Finlay; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2018-02-24       Impact factor: 5.571

7.  Phage cocktail powder for Pseudomonas aeruginosa respiratory infections.

Authors:  Mengyu Li; Rachel Yoon Kyung Chang; Yu Lin; Sandra Morales; Elizabeth Kutter; Hak-Kim Chan
Journal:  Int J Pharm       Date:  2021-01-21       Impact factor: 5.875

8.  Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.

Authors:  Amr Hassan; Dale Farkas; Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2020-10-31       Impact factor: 5.875

9.  Computational Fluid Dynamics (CFD) Simulations of Spray Drying: Linking Drying Parameters with Experimental Aerosolization Performance.

Authors:  P Worth Longest; Dale Farkas; Amr Hassan; Michael Hindle
Journal:  Pharm Res       Date:  2020-05-21       Impact factor: 4.200

10.  Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties.

Authors:  Edit Benke; Árpád Farkas; Piroska Szabó-Révész; Rita Ambrus
Journal:  Pharmaceutics       Date:  2020-06-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.